Context: Trends in symptoms and functional ability are known towards the end of life, but less is understood about quality of life, particularly prospectively following service referral.
Background
Experientially, quality of life for those with life-limiting illness is critically important, as people may prioritise quality of life over treatment that extends its quantity (1) . Palliative care services have a focus on quality of life, but access can be limited or late. Recent data indicate that people with cancer remain likely to receive aggressive end-of-life interventions including chemotherapy, repeated hospitalizations, ICU admission and late hospice or palliative care enrolment (2, 3) . Volunteer provided palliative care services designed to complement clinical care may offer options which facilitate earlier care (4, 5) .
Our study of volunteer provided palliative care services is the first reported trial in this area (6) . Whilst the intervention effect was small, the longitudinal quality of life data of those referred are a novel addition to knowledge, helping understanding of referral timing and change over time. Studies of quality of life trends for those in the palliative phase of illness are scarce, despite being perceived as an important outcome of trials of palliative care interventions (7) (8) (9) . Understanding trends in quality of life is important both clinically and to improve research so that interventions can be carefully timed, contextualised and evaluated (10) (11) (12) . Response shift is a particular concern, where people re-appraise illness and their quality of life and accommodate its challenges and their perceptions, leading to problems interpreting standard measures over time (13, 14) .
Trajectory data for people towards the end of life tends to focus on functional change, augmented with understandings of social, psychological and physical change, rather than quality of life (15, 16) . Studies use either qualitative interviews to understand change over time (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) , or measure change quantitatively (12, 28, (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) . Typically, these studies only focus on one diagnosis, track symptoms or functional change rather than quality of life, or use limited data, often from those accessing in-patient clinical services. Some explain the trajectory retrospectively from point of death, but this is less useful clinically due to the inherent problems of prognostication accuracy (48) .
Prospective studies are less common, especially for those referred to non-clinical services (49) . This study adds to knowledge by reporting longitudinal, prospectively collected, quality of life data, of those expected to be in their last year of life who were referred to volunteer provided palliative care services.
Patients and methods

Design:
This prospective, longitudinal, multicenter study of people understood to be in their last year of life assessed quality of life in the 12 weeks following referral to a volunteer provided befriending service. Data were collected in the context of a pragmatic, randomized, prospective wait-list trial; the study protocol and reports are available, and the trial prospectively registered (6, 50, 51) . The aim of this exploratory analysis was to prospectively compare the quality of life of people (with and without cancer) referred to these services.
Participants and setting:
Eligible participants were adults (≥18 years) referred to the volunteer provided palliative care services where the answer to the surprise question 'would you be surprised if the patient dies within a year?', assessed by the referring healthcare professional, was 'no' (52) . They could have any diagnosis. They had to understand or speak a language in which our main outcome measure (the WHOQOL-BREF) was available, and have an anticipated prognosis of > 4 weeks. The volunteer provided palliative care services were provided in 11 community settings across England (9 hospices, 1 alcohol and substance use charity, 1 NHS Trust). Participants continued to receive all usual care during the study. NHS Research Ethics Committee approval was received, and governance approvals from each participating site. All participants gave written consent.
Data collection:
Data were collected at study entry, and 4 and 8 weeks following that point. Those in the 'wait' arm of the trial also provided data at 12 weeks. Quality of life was assessed using the World Health Organisation Quality of Life (WHOQOL-BREF) Scale, a relatively short, but broad (26 item) non disease specific, validated self-reported measure of quality of life and wellbeing (53) . Data are reported across physical, psychological, environment and social relationship domains. Loneliness was assessed with the De Jong Gierveld 6-item Loneliness Scale, a short, well-used, reliable and valid measurement instrument (54) . Social support was assessed using the 8-item modified Medical Outcomes Study Social Support Survey (mMOS-SS), a short validated scale covering two domains of emotional and social support (55) .
Additional data included self-reported contact with health and social care services and other networks over the previous 2 weeks, and baseline socio-demographic data (age, gender, disease diagnosis, education, marital status, living status, spirituality and ethnicity). Study instruments were self-completed by participants, baseline questionnaires were explained to participants when written consent taken at a home visit, subsequent questionnaires were posted to participants' home address, selfcompleted, and returned by post to the study team.
Statistical analysis:
Participants were characterised in terms of reported primary diagnosis (cancer vs.
non-cancer), accounting for no detected difference in primary and secondary outcomes between intervention and control groups (6) . Baseline characteristics between diagnostic groups were compared using t or Chi-square test, irrespective of original random treatment allocation. To test for diagnostic status (cancer vs noncancer) effect on quality of life trajectories, we specified a series of joint models (56, 57) . These joint models simultaneously model the longitudinal outcome (quality of life) of interest and risk of death, by adjusting for participants who die earlier in the study.
In end-of-life studies and those involving older people, a significant proportion of participants may die, with survivors contributing disproportionately larger amounts of data than decedents. The tendency for healthier persons to live longer and contribute more data may lead to a "healthy survivor" effect in estimates obtained from a longitudinal analysis (58) , so it is important this is accounted for in modelling these data. As part of the joint model, we specified a linear mixed model with intercept and random slopes. We tested the main effect of time and the interaction of time with diagnostic status to evaluate for potential differences in quality of life trajectories between groups. In the Cox model, we added diagnostic group as a time-independent covariate. We used a (pseudo) adaptive Gauss-Hermite optimization algorithm(59).
We report parameter estimates, standard errors and 95% confidence intervals.
Results
Of those referred to the volunteer provided palliative care services (n=329), 196 consented to take part in the study, and 157 provided evaluable data for this analysis.
At each time point missing data were noted, but participants continued to be enrolled in the study unless advised otherwise, as data sets could be and often were returned Baseline demographic, quality of life, loneliness and social support data for the 157 participants who provided diagnostic information, enabling these analyses, are presented in table 1. There were no significant differences on demographic characteristics between those with cancer and with other non-malignant conditions. Of those without cancer, the study included those with respiratory disease (n=26), neurological disease (n=21), heart failure (n=10), liver disease (n=7), and other forms of life-limiting illness (n=8). between those with and without cancer. Those with non-malignant life limiting disease typically had worse quality of lie, were lonelier and had less social support on referral to the volunteer provided palliative care services. All differences reflect small effect sizes.
< Insert
We evaluated the distribution of quality of life at different time points by group. Despite the impact of attrition on our sample, we observed a normal distribution, with good coverage of spread of scores (Table 2, Figure 2 ). Table 2 
< Insert table 3 around here: Table 3 Change in quality of life over time>
Whilst people with cancer have a generally higher quality of life at referral to the volunteer provided palliative care service (baseline), their quality of life deteriorates significantly more rapidly over the (relatively short) data collection period to the end of the study compared to those without cancer (Figures 3 and 4) . The baseline quality of life scores of those referred to the volunteer provided palliative care services can be compared to reference data. This demonstrates that quality of life of both those with and without cancer in this sample are worse than people who are healthy or in the general population(60-62), but with similarities to those known to have life limiting illness or be users of specialist palliative care(63-65). This may indicate that the triggers for referral, at least in terms of need relating to quality of life, are similar both where referral to volunteer provided palliative care services, and a specialist palliative care service are considered. Minimal clinically important differences are not reported for the WHOQOL-BREF, but it has been reported to be sensitive to change in health status (62) . Typically half a standard deviation is considered a clinically relevant change in health related quality of life (66, 67) , a magnitude similar to the estimated change observed in our sample at the end of the study.
People with life-limiting illness who do not have cancer are known to be referred to services at a point in time where their functional status is typically worse than those with cancer. For example, those referred to specialist palliative care services with primary diagnoses other than cancer have been found to be less functional at time of referral (odds ratio: 1.6; 95% CI: 1.1, 2.3). This was felt to be because of the slower and more varied trajectory of non-cancer serious illness, typified by greater disability (40, 68) . Our data are important as they identify that this differentiation in baseline status (whether in quality of life or functional status) at point of referral to services is also true for referral to a very different volunteer provided palliative care services as for referral to specialist palliative care. Specialist palliative care is typically triggered later in the disease course for those without cancer (3, 69) , but this may not necessarily have been expected for those referred to a volunteer provided palliative care service. People with non-cancer life-limiting disease appear to have been deteriorating for a longer period of time, with more impact on quality of life, before need is recognised and referral to services made. Reasons for this may include having more time to adapt to a lower functional status, less appreciation of the life-limiting nature of the illness, less routine assessment of need, or discrimination against some disease e.g. COPD where lifestyle behaviours such as smoking contribute to risk (70) (71) (72) . In the UK hospice and palliative care services are also historically focused on, and predominantly used by, those with cancer (3, 73) .
Even over the relatively short period of time data were collected for this study, people with cancer demonstrated a more rapid deterioration in quality of life. Comparisons with other studies are challenging, as many only include people with a single diagnosis, typically cancer, but not with a comparison to other disease trajectories (28, 30-32, 37, 42, 44, 74-77) . These studies show that people with cancer do report poorer quality of life over time (44) , which is broadly characterised as a gradual decline, accelerating in the last months of life. There are studies however which do not demonstrate such changes, with no changes in quality of life found in those referred to a community palliative care service (46) , and a study of those with lung cancer which found that those with good quality of life did not change as they approached the end of life (45) . Where studies do compare people with and without cancer, typically steeper declines are found in functional status or quality of life for those with cancer (33, 34, 39) , with more disability three months prior to death (12) . Our study adds to this scarce comparative literature, strengthening the evidence base on the different trajectories of those with and without cancer at the end of life. In particular our study adds data on quality of life rather than the more typical functional status, prospectively gathered, rather than judged retrospectively from death.
The strengths of this study are in the relatively large sample, with different life-limiting illnesses, providing data prospectively over a number of time points. The follow up time points were carefully and deliberately chosen to be short, given that the study was at the end of life, and care effects need to be rapid to be worthwhile, but it is possible that a longer term follow up may reveal different trends. A potential limitation is that these data were provided in the context of an interventional trial, and this may affect people's responses to outcome measures in unanticipated ways. Diagnosis data were unavailable for 20 participants, and they had to be removed from this data set, we did not have direct access to clinical data to address this issue. This lack of access to clinical data mean that we do not know if participants were receiving any potentially disease modifying treatments which could affect quality of life. It is known that the predictive value of the surprise question in identifying those who may die is not perfect, with worse performance in non-cancer illness (78) . It may be that some of those referred are not in their last year of life, with differences in prediction between those with and without cancer. This may be why fewer of those who died were in the noncancer group. However the baseline data from both groups, and comparison to population norms, nevertheless indicates that these are groups eligible for palliative care, and we carefully controlled for survival differences in our joint model. Our data reflect 'real-life' referral patterns to a novel intervention, rather than the sample being representative of these diagnostic populations, and there is strength in these data because of this diversity. We aggregated quality of life data for those with nonmalignant conditions, as it is known that those with chronic conditions do have similar quality of life trends (62) , but it must be noted that their patterns of quality of life may not be the same.. Our study adds to knowledge methodologically by using joint models that take into account the effect of participants who die earlier in the study.
Information on the deaths of those in the study was provided contemporaneously, but exact dates of death were not known for some, and it is possible that some of those for whom we had missing data may have died.
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